skip to Main Content

Roche announce changes to compassion access program in light of Covid-19

  • 17 April 2020

We know across the world that people have been struggling to receive their Spinraza treatment because of the coronavirus causing significant hospital capacity and safety issues. Roche today have announced that they are relaxing their compassion access program eligibility criteria to help those who have been affected by this. Statement below:

Read More
Back To Top